Promega to Showcase Applications of Bioluminescent Research Tools at Global Seminar Series
Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.
Promega Corporation announced that it will showcase various applications of bioluminescence research tools at their Discover Glo 2021 conference, a virtual event which will be held Sept. 13–16, 2021.
The aim of the conference is to advance understanding in key therapeutic areas, such as targeted protein degradation and kinase biology. Each day will feature discussions focusing on a topic surrounding luciferase technologies.
These daily topics include:
- Bioluminescence: Past, Present, Future (Sept. 13)
- Applications of CRISPR Knock-in Tagging for Studying Endogenous Protein Dynamics (Sept. 14)
- Understanding Kinase Target Engagement in Live Cells (Sept. 15)
- Advances in Targeted Protein Degradation (Sept. 16)
Prominent speakers from various related fields will be in attendance. For a full list of these individuals, the company press release can be found here.
Source: Promega
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
